Flow Cytometry in Oncology Market was valued at USD 4.80 Billion in 2022 and is projected to reach USD 8.40 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030.
The flow cytometry in oncology market has shown significant growth from 2018 to 2022, driven by advancements in technology, increasing cancer prevalence, and rising demand for personalized medicine. Flow cytometry, a technology used for cell analysis, has played a pivotal role in oncology diagnostics, enabling researchers and clinicians to analyze tumor heterogeneity, immune cell profiling, and biomarker detection in cancer patients. During this period, the market expanded rapidly due to improved instruments, new reagents, and enhanced software systems that provide better data accuracy and usability.
Between 2018 and 2022, the market was largely characterized by increased adoption of flow cytometry technologies in cancer research and clinical diagnostics. Hospitals and research institutions heavily invested in flow cytometry instruments to improve their diagnostic capabilities, especially for hematologic malignancies such as leukemia and lymphoma. Additionally, companies were focused on the development of multi-parameter flow cytometry, which allows for more detailed analysis of complex cancer cell populations. This contributed to market expansion during this period, with North America leading the demand due to higher healthcare spending and a strong research base.
In terms of growth rates, the oncology segment was expected to witness a compound annual growth rate (CAGR) of 7% from 2023 to 2033. Demand for precision oncology is expected to continue driving the market as therapies such as immunotherapies and targeted therapies become more prevalent. Furthermore, the integration of artificial intelligence (AI) and machine learning with flow cytometry systems is anticipated to streamline the analysis of large datasets and improve the interpretation of results, further enhancing its role in oncology research.
The demand from 2023 to 2033 will largely stem from the increasing prevalence of cancer globally, with an estimated 19.3 million new cancer cases expected by 2025. This surge in cancer cases is expected to lead to greater demand for diagnostic and monitoring tools, particularly in personalized cancer treatment. Additionally, advancements in biomarkers for early cancer detection are set to propel the adoption of flow cytometry in oncology diagnostics. Key players in the market, such as Thermo Fisher Scientific, BD Biosciences, and Beckman Coulter, are anticipated to drive innovation through continuous product development and strategic collaborations.
Get an In-Depth Research Analysis of the Global Flow Cytometry in Oncology Market Size And Forecast [2025-2032]
Agilent Technologies
Inc.
Apogee Flow Systems Ltd.
Becton
Dickinson and Company
bioAffinity Technologies
Inc.
Bio-Rad Laboratories
Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos
S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories
Inc.
Sony Corporation
Thermo Fisher Scientific Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Flow Cytometry in Oncology Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Flow Cytometry in Oncology Market
Diagnostic Laboratories
Hospitals and Healthcare Centers
Academic and Research Institutions
Others
Based on Types the Market is categorized into Below types that held the largest Flow Cytometry in Oncology market share In 2023.
Assays and Kits
Instruments
Reagents and Consumables
Software
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Flow Cytometry in Oncology Market Research Analysis
1. Introduction of the Global Flow Cytometry in Oncology Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Flow Cytometry in Oncology Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Flow Cytometry in Oncology Market, By Type
6. Global Flow Cytometry in Oncology Market, By Application
7. Global Flow Cytometry in Oncology Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Flow Cytometry in Oncology Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/